GILEAD SCIENCES, INC. Interest Expense
GILEAD SCIENCES, INC. (GILD) reported Interest Expense of $254.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- GILEAD SCIENCES, INC. interest expense for the quarter ending 2024-03-31 was $254.00M, a 10.43% increase year-over-year.
- GILEAD SCIENCES, INC. interest expense for the quarter ending 2023-12-31 was $252.00M, a 11.50% increase year-over-year.
- GILEAD SCIENCES, INC. interest expense for the quarter ending 2023-09-30 was $232.00M, a 1.31% increase year-over-year.
- GILEAD SCIENCES, INC. interest expense for the quarter ending 2023-06-30 was $230.00M, a 4.96% decline year-over-year.
- GILEAD SCIENCES, INC. interest expense for fiscal 2023 was $944.00M, a 0.96% increase from fiscal 2022.
- GILEAD SCIENCES, INC. interest expense for fiscal 2022 was $935.00M, a 6.59% decline from fiscal 2021.
- GILEAD SCIENCES, INC. interest expense for fiscal 2021 was $1.00B, a 1.73% increase from fiscal 2020.
- GILEAD SCIENCES, INC. interest expense for fiscal 2020 was $984.00M, a 1.11% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $254.00M 10-Q · filed 2024-05-08 | $506.00M derived: sum of 2 quarters · filed 2024-05-08 | $738.00M derived: sum of 3 quarters · filed 2024-05-08 | $968.00M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-12-31 | $252.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $484.00M derived: sum of 2 quarters · filed 2024-02-23 | $714.00M derived: sum of 3 quarters · filed 2024-02-23 | $944.00M 10-K · filed 2024-02-23 | ||||
| 2023-09-30 | $232.00M 10-Q · filed 2023-11-07 | $462.00M derived: sum of 2 quarters · filed 2023-11-07 | $692.00M 10-Q · filed 2023-11-07 | $918.00M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-06-30 | $230.00M 10-Q · filed 2023-08-04 | $459.00M 10-Q · filed 2023-08-04 | $686.00M derived: sum of 3 quarters · filed 2024-05-08 | $915.00M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2023-03-31 | $230.00M 10-Q · filed 2024-05-08 | $456.00M derived: sum of 2 quarters · filed 2024-05-08 | $685.00M derived: sum of 3 quarters · filed 2024-05-08 | $927.00M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $226.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $455.00M derived: sum of 2 quarters · filed 2024-02-23 | $697.00M derived: sum of 3 quarters · filed 2024-02-23 | $935.00M 10-K · filed 2024-02-23 | ||||
| 2022-09-30 | $229.00M 10-Q · filed 2023-11-07 | $471.00M derived: sum of 2 quarters · filed 2023-11-07 | $709.00M 10-Q · filed 2023-11-07 | $947.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $242.00M 10-Q · filed 2023-08-04 | $480.00M 10-Q · filed 2023-08-04 | $718.00M derived: sum of 3 quarters · filed 2024-02-23 | $968.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $238.00M 10-Q · filed 2023-05-03 | $476.00M derived: sum of 2 quarters · filed 2024-02-23 | $726.00M derived: sum of 3 quarters · filed 2024-02-23 | $982.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $238.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $488.00M derived: sum of 2 quarters · filed 2024-02-23 | $744.00M derived: sum of 3 quarters · filed 2024-02-23 | $1.00B 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $250.00M 10-Q · filed 2022-11-02 | $506.00M derived: sum of 2 quarters · filed 2022-11-02 | $763.00M 10-Q · filed 2022-11-02 | $1.03B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $256.00M 10-Q · filed 2022-08-08 | $513.00M 10-Q · filed 2022-08-08 | $780.00M derived: sum of 3 quarters · filed 2023-02-22 | $1.02B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $257.00M 10-Q · filed 2022-05-04 | $524.00M derived: sum of 2 quarters · filed 2023-02-22 | $760.00M derived: sum of 3 quarters · filed 2023-02-22 | $1.00B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $267.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $503.00M derived: sum of 2 quarters · filed 2023-02-22 | $743.00M derived: sum of 3 quarters · filed 2023-02-22 | $984.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $236.00M 10-Q · filed 2021-11-03 | $476.00M derived: sum of 2 quarters · filed 2021-11-03 | $717.00M 10-Q · filed 2021-11-03 | $960.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $240.00M 10-Q · filed 2021-08-05 | $481.00M 10-Q · filed 2021-08-05 | $724.00M derived: sum of 3 quarters · filed 2022-02-23 | $974.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $241.00M 10-Q · filed 2021-05-06 | $484.00M derived: sum of 2 quarters · filed 2022-02-23 | $734.00M derived: sum of 3 quarters · filed 2022-02-23 | $982.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $243.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $493.00M derived: sum of 2 quarters · filed 2022-02-23 | $741.00M derived: sum of 3 quarters · filed 2022-02-23 | $995.00M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $250.00M 10-Q · filed 2020-11-04 | $498.00M derived: sum of 2 quarters · filed 2020-11-04 | $752.00M 10-Q · filed 2020-11-04 | $1.01B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $248.00M 10-Q · filed 2020-08-06 | $502.00M 10-Q · filed 2020-08-06 | $759.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.02B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $254.00M 10-Q · filed 2020-05-06 | $511.00M derived: sum of 2 quarters · filed 2021-02-25 | $775.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.04B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $257.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $521.00M derived: sum of 2 quarters · filed 2021-02-25 | $787.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.08B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $264.00M 10-Q · filed 2019-11-05 | $530.00M derived: sum of 2 quarters · filed 2019-11-05 | $820.00M 10-Q · filed 2019-11-05 | $1.12B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $266.00M 10-Q · filed 2019-08-06 | $556.00M 10-Q · filed 2019-08-06 | $853.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.14B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $290.00M 10-Q · filed 2019-05-08 | $587.00M derived: sum of 2 quarters · filed 2020-02-25 | $878.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.15B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $297.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $588.00M derived: sum of 2 quarters · filed 2020-02-25 | $857.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.12B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $291.00M 10-Q · filed 2018-11-06 | $560.00M derived: sum of 2 quarters · filed 2018-11-06 | $821.00M 10-Q · filed 2018-11-06 | $1.09B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $269.00M 10-Q · filed 2018-08-06 | $530.00M 10-Q · filed 2018-08-06 | $795.00M derived: sum of 3 quarters · filed 2019-02-26 | $1.04B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $261.00M 10-Q · filed 2018-05-09 | $526.00M derived: sum of 2 quarters · filed 2019-02-26 | $768.00M derived: sum of 3 quarters · filed 2019-02-26 | $995.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $265.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $507.00M derived: sum of 2 quarters · filed 2019-02-26 | $734.00M derived: sum of 3 quarters · filed 2019-02-26 | $964.00M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $242.00M 10-Q · filed 2017-11-07 | $469.00M derived: sum of 2 quarters · filed 2017-11-07 | $699.00M 10-Q · filed 2017-11-07 | $929.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $227.00M 10-Q · filed 2017-08-07 | $457.00M 10-Q · filed 2017-08-07 | $687.00M derived: sum of 3 quarters · filed 2018-02-27 | $852.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $230.00M 10-Q · filed 2017-05-10 | $460.00M derived: sum of 2 quarters · filed 2018-02-27 | $625.00M derived: sum of 3 quarters · filed 2018-02-27 | $765.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $230.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $395.00M derived: sum of 2 quarters · filed 2018-02-27 | $535.00M derived: sum of 3 quarters · filed 2018-02-27 | $688.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $165.00M 10-Q · filed 2016-11-07 | $305.00M derived: sum of 2 quarters · filed 2016-11-07 | $458.00M 10-Q · filed 2016-11-07 | $588.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $140.00M 10-Q · filed 2016-08-05 | $293.00M 10-Q · filed 2016-08-05 | $423.00M derived: sum of 3 quarters · filed 2017-02-27 | $527.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $153.00M 10-Q · filed 2016-05-06 | $283.00M derived: sum of 2 quarters · filed 2017-02-27 | $387.00M derived: sum of 3 quarters · filed 2017-02-27 | $489.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $130.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $234.00M derived: sum of 2 quarters · filed 2017-02-27 | $336.00M derived: sum of 3 quarters · filed 2017-02-27 | $412.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $104.00M 10-Q · filed 2015-11-04 | $103.37M 10-Q · filed 2014-11-05 | $206.00M derived: sum of 2 quarters · filed 2015-11-04 | $282.00M 10-Q · filed 2015-11-04 | $281.64M 10-Q · filed 2014-11-05 | $355.26M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $102.00M 10-Q · filed 2015-08-05 | $102.00M 10-Q · filed 2014-08-04 | $178.00M 10-Q · filed 2015-08-05 | $178.27M 10-Q · filed 2014-08-04 | $251.26M derived: sum of 3 quarters · filed 2016-02-24 | $325.20M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $76.00M 10-Q · filed 2015-05-08 | $76.27M 10-Q · filed 2014-05-07 | $149.26M derived: sum of 2 quarters · filed 2016-02-24 | $223.21M derived: sum of 3 quarters · filed 2016-02-24 | $301.21M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $73.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $147.21M derived: sum of 2 quarters · filed 2016-02-24 | $225.21M derived: sum of 3 quarters · filed 2016-02-24 | $307.00M 10-K · filed 2016-02-24 | $306.89M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $73.95M 10-Q · filed 2014-11-05 | $151.96M derived: sum of 2 quarters · filed 2014-11-05 | $233.74M 10-Q · filed 2014-11-05 | $319.73M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $78.01M 10-Q · filed 2014-08-04 | $159.79M 10-Q · filed 2014-08-04 | $245.78M derived: sum of 3 quarters · filed 2015-02-25 | $335.11M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $81.79M 10-Q · filed 2014-05-07 | $167.78M derived: sum of 2 quarters · filed 2015-02-25 | $257.10M derived: sum of 3 quarters · filed 2015-02-25 | $345.52M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $85.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $175.31M derived: sum of 2 quarters · filed 2015-02-25 | $263.73M derived: sum of 3 quarters · filed 2015-02-25 | $361.00M 10-K · filed 2015-02-25 | $360.92M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $89.32M 10-Q · filed 2013-10-31 | $177.74M derived: sum of 2 quarters · filed 2013-10-31 | $275.01M 10-Q · filed 2013-10-31 | $350.01M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $88.42M 10-Q · filed 2013-08-01 | $185.69M 10-Q · filed 2013-08-01 | $260.69M derived: sum of 3 quarters · filed 2014-02-25 | $303.78M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $97.27M 10-Q · filed 2013-05-08 | $172.27M derived: sum of 2 quarters · filed 2014-02-25 | $215.37M derived: sum of 3 quarters · filed 2014-02-25 | $261.47M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $118.09M derived: sum of 2 quarters · filed 2014-02-25 | $164.20M derived: sum of 3 quarters · filed 2014-02-25 | $205.42M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $43.10M 10-Q · filed 2012-11-06 | $89.20M derived: sum of 2 quarters · filed 2012-11-06 | $130.42M 10-Q · filed 2012-11-06 | $171.04M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $46.11M 10-Q · filed 2012-08-01 | $87.32M 10-Q · filed 2012-08-01 | $127.94M derived: sum of 3 quarters · filed 2013-02-27 | $161.56M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $41.22M 10-Q · filed 2012-05-04 | $81.84M derived: sum of 2 quarters · filed 2013-02-27 | $115.46M derived: sum of 3 quarters · filed 2013-02-27 | $133.22M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $40.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $74.24M derived: sum of 2 quarters · filed 2013-02-27 | $92.01M derived: sum of 3 quarters · filed 2013-02-27 | $108.96M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $33.62M 10-Q · filed 2011-11-04 | $51.38M derived: sum of 2 quarters · filed 2011-11-04 | $68.34M 10-Q · filed 2011-11-04 | $85.63M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $17.76M 10-Q · filed 2011-08-05 | $34.72M 10-Q · filed 2011-08-05 | $52.01M derived: sum of 3 quarters · filed 2012-02-23 | $69.23M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $16.95M 10-Q · filed 2011-05-09 | $34.24M derived: sum of 2 quarters · filed 2012-02-23 | $51.46M derived: sum of 3 quarters · filed 2012-02-23 | $69.95M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $17.29M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $34.51M derived: sum of 2 quarters · filed 2012-02-23 | $52.99M derived: sum of 3 quarters · filed 2012-02-23 | $69.66M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $17.22M 10-Q · filed 2010-11-08 | $35.70M derived: sum of 2 quarters · filed 2010-11-08 | $52.37M 10-Q · filed 2010-11-08 | $68.81M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $18.48M 10-Q · filed 2010-08-09 | $35.16M 10-Q · filed 2010-08-09 | $51.59M derived: sum of 3 quarters · filed 2011-02-28 | $67.97M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $16.67M 10-Q · filed 2010-05-10 | $33.10M derived: sum of 2 quarters · filed 2011-02-28 | $49.49M derived: sum of 3 quarters · filed 2011-02-28 | $65.91M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $32.81M derived: sum of 2 quarters · filed 2011-02-28 | $49.24M derived: sum of 3 quarters · filed 2011-02-28 | $65.24M 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $16.38M 10-Q · filed 2009-11-05 | $32.81M derived: sum of 2 quarters · filed 2009-11-05 | $48.81M 10-Q · filed 2009-11-05 | |||||
| 2008-06-30 | $16.43M 10-Q · filed 2009-08-05 | $32.43M 10-Q · filed 2009-08-05 | ||||||
| 2007-12-31 | $63.18M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |